Figure 37 displays a graph of the risk of skin flushing across interventions. There were 8 different drug combinations, as well as placebo, that were associated with skin flushing. The lowest risks were seen in droperidol and metoclopramide plus pethidine while the highest risks were seen in DHE and metoclopramide plus magnesium sulphate.

Figure 37Risk of skin reaction reported in acute migraine trials

From: Results

Cover of Acute Migraine Treatment in Emergency Settings
Acute Migraine Treatment in Emergency Settings [Internet].
Comparative Effectiveness Reviews, No. 84.
Sumamo Schellenberg E, Dryden DM, Pasichnyk D, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.